$VYGR
Voyager Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$2.49
▲+1.22%+$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateVoyager Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is VYGR up today? It is at $2.49 (+1.22%), and our scanner flagged it 47 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VYGR spikes, and full due diligence on VYGR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VYGR 47 times in the last 30 days. Create a free account to track $VYGR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VYGR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VYGR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystVoyager Reports Second Quarter 2026 Financial and Operating ResultsReported - Ended Q2 2026 with cash position of $149 million, runway into 2028 -, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedAug 14, 2026 · 54 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sandrock Alfred Officer | Sold (automatic/other) | -12K 0.02% of company | sold 2.4% | 473K | $45K at $3.87 | Apr 2, 26 |
Shiferman Gregory L. Officer | Acquired (grant/award) | +50K 0.08% of company | n/a | 50K | n/a | Apr 1, 26 |
Carter Todd Alfred Officer | Sold (automatic/other) | -4K | sold 2.8% | 146K | $16K at $3.76 | Feb 24, 26 |
Jorgensen Nathan D. Officer | Sold (automatic/other) | -5K | sold 3.0% | 151K | $18K at $3.77 | Feb 24, 26 |
Sandrock Alfred Officer | Sold (automatic/other) | -14K 0.02% of company | sold 2.8% | 484K | $54K at $3.79 | Feb 24, 26 |
Swartz Robin Officer | Sold (automatic/other) | -6K 0.01% of company | sold 3.1% | 200K | $24K at $3.77 | Feb 24, 26 |
Sandrock Alfred Officer | Sold (automatic/other) | -12K 0.02% of company | sold 2.3% | 498K | $40K at $3.41 | Feb 18, 26 |
Carter Todd Alfred Officer | Sold (automatic/other) | -3K | sold 2.2% | 150K | $11K at $3.44 | Feb 18, 26 |
Swartz Robin Officer | Sold (automatic/other) | -4K | sold 1.8% | 206K | $13K at $3.44 | Feb 18, 26 |
Carter Todd Alfred Officer | Sold (automatic/other) | -4K | sold 2.2% | 153K | $14K at $3.85 | Feb 10, 26 |
Sandrock Alfred Officer | Sold (automatic/other) | -12K 0.02% of company | sold 2.3% | 510K | $46K at $3.78 | Feb 10, 26 |
Swartz Robin Officer | Sold (automatic/other) | -5K | sold 2.1% | 210K | $18K at $3.85 | Feb 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on VYGR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VYGR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VYGR last traded at $2.49, up 1.22% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Voyager Therapeutics, Inc. Common Stock (VYGR) is next expected to report earnings on Monday, November 9, 2026, about 33 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VYGR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VYGR 47 times in the last 30 days.
VYGR (Voyager Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $152M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VYGR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VYGR discussion
Sign in to ask a question or join the discussion.